Figure 1: First idea sketches.
Together with other design students, we created a different kind of ideas for the HDRK. With those sketches, we decided to make 3 different concepts.
Figure 2: Concept 1.
Figure 3: Concept 2.
Figure 4: Concept 3.
Concept 3, the test with display, got shot down. The main reason, it would be a bit too expensive if the user throw the whole product away after every single use.
For the two main designs, the team suggested a combination of the two: the design of the analog test and the material of the decomposable test. With this feedback we created the first HRDK.
Figure 5: First poster of HRDK and our stellation at Future Flux Festival.
http://www.futurefluxfestival.nl/industry-day/health-risk-detection-kit-hrd/
At the Future Flux, we presented our first idea to get some feedback, to develop our product and process. The most important points were: how many checks, size of the test and how to use the HRDK.
Figure 6: Difference in size of the first HRDK and the last HRDK.
After we have received all the feedback, we started to make a new design.
In this design (8), we could intergrade four detection systems. Two extra control points are required for reliability: one positive and one negative control. The channels must also be of the same length. For capillary working, we have to make the channels smaller.
Figure 7: First engineering.
We changed the model with these requirements. Only after we showed this test to Jos (instructor) he suggested making 4 more viewpoints to see the substrate.
Figure 8: Second engineering.
Figure 9: Third engineering.
Figure 10: System with the 3 wells per target.
For each target there are 3 wells, on each well we will have our system dried on paper. One well is for the negative control (yellow). In this well we will have our system without the split-TEV proteins, because without TEV, the inhibitor will not be cleaved off from β-Lactamase. So, there will be no color change.
The second well is for our positive control (red). In this well we will have our system, but instead of the split-TEV proteins, there will be a functional TEV. In this case it shouldn't matter if the target is present, because TEV will cleave of the inhibitor from β-Lactamase anyway.
The last well is for our sample (yellow or red). In this well will be our system as described on the description page.